InsiderClue
Insiders · Profile

Raymon Heather

SVP, Research and Development at Artiva Biotherapeutics. Filing since 19 May 2026. CIK 0002028466

Company
Date
Role
Action
Shares
Amount
Of holding
ARTV Artiva Biotherapeutics, Inc.
19 May 2026
SVP, Research and Development
Sold at will
3,095
$27.88K
2.0%
1 decision on file.